Search for: "ACTAVIS, INC." Results 61 - 80 of 382
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Sep 2018, 6:48 am by Law Offices of Jeffrey S. Glassman
Current drugs subject to recall include: Tablets sold by firms AvKare (Teva/Actavis) and (Hetero/Camber), A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco), Bryant Ranch Prepack Inc, (Teva/Actavis), Hetero Labs (labeled as Camber Pharmaceuticals Inc.), H J Harkins Co., Northwind Pharmaceuticals (Teva/Actavis), NuCare Pharmaceuticals Inc. [read post]
6 Sep 2018, 5:38 pm by Lawrence B. Ebert
TWi Pharms., Inc., 265 F.Supp. 3d 490 (D.N.J. 2017). [read post]
20 Jun 2018, 4:12 am by Simon Holzer
Note that Meyerlustenberger Lachenal AG has been involved in this matter on behalf of Gilead) The Swiss dispute in a nutshell The Swiss litigation is about the validity of Gilead Sciences Inc. [read post]
25 May 2018, 9:27 am
The case of Edwards Lifesciences LLC v Boston Scientific Scimed Inc & Ors [2018] EWHC 1256 (Pat) handed down yesterday, is a little more nuanced. [read post]
29 Jan 2018, 2:57 am
 The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
5 Dec 2017, 12:29 pm by Overhauser Law Offices, LLC
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
1 Dec 2017, 6:20 am
The panel discussion was on the doctrine of equivalents following the Actavis v Lilly decision. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
15 Nov 2017, 4:00 am by Kimberly A. Kralowec
Actavis, Inc., ___ Cal.App.5th ___ (Nov. 6, 2017), the Court of Appeal (Fourth Appellate District, Division Three) considered whether the defendant pharmaceutical companies' CGL insurance policies required the insurers to defend a UCL "public prosecutor" action brought by Santa Clara and Orange Counties. [read post]